New combo treatment aims to help veterans quit smoking and manage PTSD
NCT ID NCT03978442
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 34 times
Summary
This study tested a treatment called CPT-SMART that combines PTSD therapy, smoking cessation counseling, medication, and financial incentives to help veterans quit smoking. 120 veteran smokers with PTSD were randomly assigned to either the full program or a control group. The goal was to see if this combined approach leads to higher quit rates and better engagement in treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupropion (Zyban)
What this could lead to
If successful, this approach could provide an effective way to help veterans with PTSD quit smoking, reducing smoking-related illness and death.
What could go wrong
This is a completed Phase 4 trial with 120 participants, so results are available but may not apply to all smokers with PTSD. The intervention is complex and may not be widely adopted.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.